Description |
CREB binding protein |
peroxisome proliferator activated receptor gamma |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Alpha-Linolenic Acid
- Icosapent
- Troglitazone
- Mesalazine
- Valproic Acid
- Indomethacin
- Rosiglitazone
- Fenoprofen
- Nateglinide
- Sulfasalazine
- Repaglinide
- Telmisartan
- Balsalazide
- Fenofibrate
- Ibuprofen
- Glipizide
- Amiodarone
- Pioglitazone
- Mitiglinide
- Bezafibrate
- Flufenamic Acid
- Resveratrol
- Phthalic Acid
- Capric acid
- Doconexent
- Oleic Acid
- (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid
- 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
- Reglixane
- Elafibranor
- T131
- CLX-0921
- (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
- (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
- 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
- (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid
- (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid
- (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid
- (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid
- (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid
- difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron
- (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID
- 3-(5-methoxy-1H-indol-3-yl)propanoic acid
- Indeglitazar
- (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
- 2-chloro-5-nitro-N-phenylbenzamide
- (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
- 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
- 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
- (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
- 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
- Triclosan
- (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid
- Aleglitazar
- Clinofibrate
- Lobeglitazone
- Ciglitazone
- Dexibuprofen
- Omega-3 fatty acids
- Curcumin
- Arhalofenate
|
Diseases |
|
|
GWAS |
- Heel bone mineral density ( 30598549)
- Metabolite levels (HVA/5-HIAA ratio) ( 23319000)
- Nonsyndromic cleft lip with cleft palate ( 28232668)
- Nonsyndromic cleft lip with or without cleft palate ( 25775280)
- Obesity-related traits ( 23251661)
- Pre-treatment viral load in HIV-1 infection ( 31219150)
- QT interval ( 24952745)
- QT interval (drug interaction) ( 23459443)
|
- Arterial stiffness index ( 31235810)
- Body mass index ( 28892062 25673413 29273807)
- Cholesterol, total ( 25961943)
- Drug-induced liver injury ( 22968431)
- Endometrial cancer ( 30093612)
- Endometrial cancer (endometrioid histology) ( 30093612)
- Eosinophil counts ( 27863252)
- Eosinophil percentage of granulocytes ( 27863252)
- Eosinophil percentage of white cells ( 27863252)
- Fasting blood insulin ( 25631608)
- Fasting blood insulin (BMI interaction) ( 22581228)
- Fasting blood insulin adjusted for BMI ( 25625282)
- Gut microbiota (functional units) ( 27694959)
- HDL cholesterol ( 30275531)
- Heel bone mineral density ( 30598549)
- Hematocrit ( 27863252)
- Hemoglobin concentration ( 27863252)
- High density lipoprotein cholesterol levels ( 29403010)
- Hip circumference adjusted for BMI ( 25673412)
- Idiopathic osteonecrosis of the femoral head ( 31135556)
- LDL cholesterol ( 25961943)
- LDL cholesterol levels ( 30698716)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Medication use (drugs used in diabetes) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Medication use (thyroid preparations) ( 31015401)
- Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI) ( 27416945)
- Neutrophil percentage of granulocytes ( 27863252)
- Plasminogen activator inhibitor type 1 levels (PAI-1) ( 22990020)
- Platelet count ( 29403010)
- Potassium levels ( 29403010)
- Sexual dimorphism in anthropometric traits ( 23754948)
- Systemic lupus erythematosus ( 28714469)
- Type 2 diabetes ( 22885922 18372903 24509480 30054458 29358691 30297969 29632382 31118516 20581827 17463246 30718926 17463248 17463249 28869590)
- Type 2 diabetes (adjusted for BMI) ( 29632382)
- Waist circumference ( 31453325)
- Waist circumference variance ( 31453325)
- Waist-hip ratio ( 25673412)
- Waist-to-hip ratio adjusted for BMI ( 26426971)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) ( 28448500)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist-to-hip ratio adjusted for BMI in active individuals ( 28448500)
- Waist-to-hip ratio adjusted for BMI in non-smokers ( 28443625)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 25673412 28448500)
|
Interacting Genes |
292 interacting genes:
ACTA2
ACVR1
AIRE
AKT1
ALX1
ANAPC5
ANAPC7
AP1B1
APC
AR
ATF1
ATF3
ATF4
ATF7IP
ATRX
BCL3
BCL6
BRCA1
BRIP1
CALCOCO1
CAMK4
CARM1
CASP8AP2
CBX4
CDC25B
CDH2
CDK5RAP3
CDX2
CEBPA
CEBPB
CEBPD
CENPJ
CHAF1A
CHD3
CHUK
CITED1
CITED2
CNOT3
CPSF4
CREB1
CREM
CRX
CSK
CSNK2A1
CSNK2A2
CTBP1
CTNNB1
CUX1
DACH1
DAXX
DDX17
DDX5
DEK
E2F1
E2F3
E2F5
EBF1
EGR1
EID1
EID3
EIF2B1
EIF3D
ELF3
ELK1
EP300
ESR1
ETS1
ETS2
EWSR1
FAF1
FBXL19
FBXO38
FGFR1
FHL2
FOS
FOXM1
FOXO1
FOXO4
GABPA
GAK
GATA1
GATAD2A
GCM1
GLI3
GMEB1
GMEB2
GTF2B
H2BC21
H2BC3
H3-3A
H3-4
H3C1
H4-16
H4C1
HBP1
HCK
HDAC1
HDAC3
HIF1A
HIPK1
HIPK2
HIPK3
HLF
HMGA1
HMGB1
HMGB2
HMGXB4
HNF1A
HNF1B
HNF4A
HOXA10
HOXA11
HOXA9
HOXB1
HOXB2
HOXB3
HOXB4
HOXB6
HOXB7
HOXB9
HOXD10
HOXD12
HOXD13
HOXD4
HSF1
HTT
IKBKG
IRF1
IRF3
IRF5
IRF7
JDP2
JUN
KAT2A
KAT2B
KAT5
KAT6A
KDM3B
KHDRBS1
KISS1
KLF1
KLF13
KLF4
KLF5
KMT2A
KPNA2
KPNA6
LDLR
LIG4
LYN
MAF
MAFG
MAML1
MAML2
MAP3K5
MAPK1
MAPK10
MAPK3
MAPT
MBD2
MDC1
MDM2
MECOM
MED25
MGMT
MIER1
MKNK1
MSH2
MSH6
MSX1
MYB
MYBL1
MYBL2
MYC
MYOD1
N4BP2
NAP1L1
NCOA1
NCOA2
NCOA3
NCOA6
NEUROG1
NFATC2
NFATC4
NFE2
NFE2L2
NFIA
NFIC
NKX2-1
NLK
NPAS2
NPAT
NR3C1
NR5A1
NUP98
ONECUT1
PARP1
PAX5
PBX1
PCMT1
PCNA
PELP1
PHOX2A
PIAS1
PIAS2
PIAS3
PLAGL1
PML
POLR2A
POU1F1
POU2F3
PPARG
PPARGC1A
PPP1R8
PPP2R2A
PRKCD
PRLR
PROX1
PSME3
PTMA
PTPRF
RAD23A
RBBP4
RBBP7
RBCK1
RELA
RNF111
RPL3
RPL35
RPS6KA1
RPS6KA3
RPS6KA5
RXRG
SERTAD1
SERTAD2
SERTAD3
SETDB1
SH3GL1
SMAD2
SMAD3
SMAD4
SND1
SNIP1
SOX9
SP100
SPI1
SPIB
SRCAP
SREBF1
SREBF2
SRF
SS18L1
STAT1
STAT2
STAT3
STAT4
STAT6
SUMO1
SUV39H1
TACC2
TAF6L
TCF12
TCF3
TDG
TFDP1
TGS1
THRA
TOPORS
TP53
TP73
TRERF1
TRIP10
TRIP4
UBE2D1
UBE2I
UBTF
UIMC1
VDR
WDR77
WT1
XAF1
XRCC6
YWHAH
ZBTB17
ZBTB2
ZCCHC7
ZHX1
ZMYM2
ZMYM5
ZNF451
ZNF639
ZNFX1
|
106 interacting genes:
ALOX15B
ANP32A
APP
BCAS2
BRD8
CDC34
CDK5
CEP350
CNOT1
COPS5
CREBBP
DNTTIP2
EDF1
EGFR
FABP1
FHOD1
FOXO1
GADD45B
GADD45G
GRIP1
HDAC1
HDAC3
HDAC4
HELZ2
HMGA1
IGFBP3
IKBKB
JAZF1
JMJD1C
JUN
JUND
KAT2A
KAT5
KCTD13
KIF11
KIF1A
KLF5
LMO4
LRIF1
MAFF
MAP2K1
MAPK1
MAPK8
MED1
MED24
MFHAS1
MIF4GD
MSX2
MUC1
NCOA1
NCOA2
NCOA3
NCOA4
NCOA6
NCOR1
NCOR2
NFE2L2
NFE2L3
NFKB1
NFKBIB
NR0B1
NR0B2
NR2E3
NR4A1
NR4A2
NRIP1
NSD1
PAK4
PDIA2
PHB2
PML
POU1F1
PPARGC1A
PPM1B
PRKCA
RAD54L2
RANBP9
RB1
RELA
ROBO4
RXRA
RXRB
RXRG
SERPINH1
SFPQ
SIRT1
SMARCD3
STAT6
STUB1
SVIL
SYT1
TFAP2A
TNP1
TRIM24
TRIP4
UBC
UBE2I
USP7
VDR
ZBTB20
ZBTB3
ZBTB5
ZBTB9
ZNF496
ZNHIT3
ZSCAN1
|
Entrez ID |
1387 |
5468 |
HPRD ID |
02534 |
03288 |
Ensembl ID |
ENSG00000005339
|
ENSG00000132170
|
Uniprot IDs |
Q92793
|
A0A494C1F9
D2KUA6
E9PFX5
P37231
|
PDB IDs |
1JSP
1LIQ
1RDT
1WO3
1WO4
1WO5
1WO6
1WO7
1ZOQ
2D82
2KJE
2KWF
2L84
2L85
2LXS
2LXT
2N1A
2RNY
3DWY
3P1C
3P1D
3P1E
3P1F
3SVH
4A9K
4N3W
4N4F
4NR4
4NR5
4NR6
4NR7
4NYV
4NYW
4NYX
4OUF
4TQN
4TS8
4WHU
4YK0
5CGP
5DBM
5EIC
5ENG
5EP7
5GH9
5H85
5I83
5I86
5I89
5I8B
5I8G
5J0D
5JEM
5KTU
5KTW
5KTX
5LPJ
5LPL
5MME
5MMG
5MPK
5MPN
5MPZ
5MQE
5MQG
5MQK
5NLK
5NRW
5NU3
5OWK
5SVH
5TB6
5W0E
5W0F
5W0L
5W0Q
5XXH
6ALB
6ALC
6AXQ
6AY3
6AY5
6DMK
6ES5
6ES6
6ES7
6FQO
6FQT
6FQU
6FR0
6FRF
|
1FM6
1FM9
1I7I
1K74
1KNU
1NYX
1PRG
1RDT
1WM0
1ZEO
1ZGY
2ATH
2F4B
2FVJ
2G0G
2G0H
2GTK
2HFP
2HWQ
2HWR
2I4J
2I4P
2I4Z
2OM9
2P4Y
2POB
2PRG
2Q59
2Q5P
2Q5S
2Q61
2Q6R
2Q6S
2Q8S
2QMV
2VSR
2VST
2VV0
2VV1
2VV2
2VV3
2VV4
2XKW
2YFE
2ZK0
2ZK1
2ZK2
2ZK3
2ZK4
2ZK5
2ZK6
2ZNO
2ZVT
3ADS
3ADT
3ADU
3ADV
3ADW
3ADX
3AN3
3AN4
3B0Q
3B0R
3B1M
3B3K
3BC5
3CDP
3CDS
3CS8
3CWD
3D6D
3DZU
3DZY
3E00
3ET0
3ET3
3FEJ
3FUR
3G9E
3GBK
3H0A
3HO0
3HOD
3IA6
3K8S
3KMG
3LMP
3NOA
3OSI
3OSW
3PBA
3PO9
3PRG
3QT0
3R5N
3R8A
3R8I
3S9S
3SZ1
3T03
3TY0
3U9Q
3V9T
3V9V
3V9Y
3VJH
3VJI
3VN2
3VSO
3VSP
3WJ4
3WJ5
3WMH
3X1H
3X1I
4A4V
4A4W
4CI5
4E4K
4E4Q
4EM9
4EMA
4F9M
4FGY
4HEE
4JAZ
4JL4
4L96
4L98
4O8F
4OJ4
4PRG
4PVU
4PWL
4R06
4R2U
4R6S
4XLD
4XTA
4XUH
4XUM
4Y29
4YT1
5AZV
5DSH
5DV3
5DV6
5DV8
5DVC
5DWL
5F9B
5GTN
5GTO
5GTP
5HZC
5JI0
5LSG
5TTO
5TWO
5U5L
5UGM
5WQX
5WR0
5WR1
5Y2O
5Y2T
5YCN
5YCP
5Z5S
5Z6S
6AD9
6AN1
6AUG
6AVI
6C1I
6C5Q
6C5T
6D3E
6D8X
6D94
6DBH
6DCU
6DGL
6DGO
6DGP
6DGQ
6DGR
6DH9
6DHA
6E5A
6ENQ
6F2L
6FZF
6FZG
6FZJ
6FZP
6FZY
6ICJ
6IJR
6IJS
6ILQ
6IZM
6IZN
6JQ7
6K0T
6MCZ
6MD0
6MD1
6MD2
6MD4
6MS7
6O67
6O68
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|